News
Medicines UK has a range of experts who can talk about the themes, issues and trends which impact the manufacture and supply of medicines. For any members of the media looking for comment, briefings or an interview, please get in contact with Jeremy Durrant on 0787 9654 0206 or email jeremy.durrant@medicinesuk.com.
NEWS CATEGORIES
Partnership will revive inactive licences to solve critical medicines shortages
By Jeremy Durrant
News archive
2025
26.11.2025 - Medicines UK Supply Issue Dashboard November 2025
12.11.2025 - The future role of off patent medicines in delivering integrated care
12.11.2025 - Better Health, Better Access, Better Value
26.09.2025 - Medicines UK Supply Issue Dashboard September 2025
08.08.2025 - Medicines UK Supply Issue Dashboard August 2025
25.07.2025 - Reaction to UK / India free trade deal
17.07.2025 - Government's life sciences strategy reaction
03.07.2025 - NHS 10-year plan reaction
20.06.2025 - Medicines UK Supply Issue Dashboard June 2025
20.05.2025 - Medicines UK Supply Issue Dashboard April 2025
18.03.2025 - Medicines UK supply issues dashboard March 2025
28.02.2025 - Off-patent savings watch: H1 2025
11.02.2025 - Medicines UK supply issues dashboard February 2025
29.01.2025 - Medicines UK supply issues dashboard January 2025
2024
16.12.2024 - 2025 VPAG Rebate Rate
09.12.2024 - Medicines UK supply issue dashboard November 2024
05.12.2024 - Genericisation of the first wave of GLP-1 weight loss medicines report
26.11.2024 - Response to Royal Pharmaceutical Society Report into shortages
20.11.2024 - First wave of generic weight loss medicines available in the UK
13.11.2024 - Medicines UK names first womens working group chair
31.10.2024 - Medicines UK supply issue dashboard October 2024
01.10.2024 - Solutions to UK Medicines Shortages
24.09.2024 - Medicines UK supply issue dashboard September 2024
20.08.2024 - Medicines UK Supply issue dashboard August 2024
22.07.2024 - Medicines UK Supply issue dashboard July 2024
11.06.2024 - Medicines UK Supply issue dashboard June 2024
11.06.2024 - Paul Burden elected Medicines UK vice-chair
10.05.2024 - Medicines UK supply issue dashboard May 2024
03.04.2024 - Medicines UK supply issue dashboard April 2024
18.03.2024 - Medicines UK Manifesto March 2024
14.02.2024 - Medicines UK supply issue dashboard February 2024
24.01.2024 - Medicines UK supply issue dashboard January 2024
30.01.2024 - Reaction to Labour's Life Sciences Strategy
2023
18.12.2023 - Medicines UK supply issue dashboard December 2023
05.12.2023 - Viatris Country Manager elected UK Trade Association, Medicines UK, Vice-Chair
31.10.2023 - Medicines UK supply issue dashboard October 2023
21.11.2023 - VPAG Heads of Agreement Reaction
06.11.2023 - Spiralling VPAS rebate starts to bite as record number of medicines face supply issues
30.10.2023 - "Spiralling" Government tax threatens to add millions to local NHS budgets
11.10.2023 - Statutory Scheme Consultation Response
01.09.2023 - Medicines UK supply issue dashboard September 2023
03.08.2023 - Statutory Scheme Response
17.07.2023 - Medicines UK supply issue dashboard July 2023
10.07.2023 - Medicines UK Warns of Significant Implications From Crippling VPAS Rate
15.06.2023 - Medicines UK supply issue dashboard June 2023
15.06.2023 - Billions of pounds of NHS savings under threat from rising Government tax
03.05.2023 - Medicines UK supply issue dashboard May 2023
15.05.2023 - Medicines UK Elects New Association Vice Chair
21.04.2023 - VPAS Update - Judicial Review
03.03.2023 - Medicines UK supply issue dashboard March 2023
28.02.2023 - Statement on Northern Ireland Protocol
06.01.2023 - Medicines UK supply issue dashboard January 2023
2022
14.12.2022 - VPAS Rise Rate 2023
14.12.2022 - Medicines UK supply issue dashboard December 2022
03.11.2022 - Medicines UK supply issue dashboard November 2022
06.10.2022 - Medicines UK supply issue dashboard October 2022
07.09.2022 - Medicines UK supply issue dashboard September 2022
17.08.2022 - Medicines UK supply issue dashboard August 2022
21.07.2022 - Medicines UK supply issue dashboard July 2022
14.06.2022 - Medicines UK supply issue dashboard June 2022
31.05.2022 - Pete Kelly Voted New Chair of Medicines UK
08.03.2022 - Medicines UK supply issues dashboard February 2022
24.01.2022 - Medicines UK supply issues dashboard January 2022
2021
22.12.2021 - Updated Statement on supply of medicines to Northern Ireland
17.12.2021 - Statement on Northern Ireland Protocol
26.11.2021 - Medicines UK supply issues dashboard November 2021
02.11.2021 - Medicines UK supply issues dashboard October 2021
21.10.2021 - Updated statement on Northern Ireland Protocol and Supply of Medicines
15.09.2021 - Medicines UK supply issues dashboard September 2021
16.08.2021 - Medicines UK supply issues dashboard August 2021
22.07.2021 - Statement on current supply situation to Northern Ireland
20.07.2021 - Medicines UK supply issues dashboard July 2021
07.07.2021 - Reaction to Office for Life Sciences Vision
21.06.2021 - Medicines UK supply issues dashboard June 2021
21.05.2021 - Medicines UK supply issues dashboard May 2021
20.04.2021 - Medicines UK supply issues dashboard April 2021
25.03.2021 - Reaction to the establishment of the UK Health Security Agency
16.03.2021 - Batch testing announcement and review
18.02.2021 - Medicines UK Appoints Mark Samuels as New CEO
2020
06.11.2020 - Joint EU-UK pharmaceutical industry response to Specialised Committee outcome
09.10.2020 - MHRA guidance on the licensing of biosimilar products
07.10.2020 - CMA investigation into lithium based medicines
26.08.2020 - Trade Advisory Group Appointment
25.06.2020 - Life Sciences Recovery Roadmap
16.06.2020 - Reaction to dexamethasone treatment for Covid-19 patients
21.04.2020 - A video message from our chair Tim de Gavre on the current Covid-19 pandemic.
02.04.2020 - Statement of intent for UK life sciences
25.03.2020 - COVID-19 Medicines UK update
20.03.2020 - Key worker welcome
18.03.2020 - Covid-19 statement
04.03.2020 - Response to today's CMA fines on anti-competitive agreements